User profiles for Silje Nord
Silje Nord (Maiden name: Nordgard)Dep. of Genetics, Inst. for Cancer Research, DNR Verified email at rr-research.no Cited by 6033 |
Prediction of breast cancer risk based on profiling with common genetic variants
…, G Grenaker Alnæs, S Nord… - Journal of the …, 2015 - academic.oup.com
Background: Data for multiple common susceptibility alleles for breast cancer may be combined
to identify women at different levels of breast cancer risk. Such stratification could guide …
to identify women at different levels of breast cancer risk. Such stratification could guide …
Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer
…, CN Hsiung, PE Wu, MF Hou, VN Kristensen, S Nord… - Nature …, 2015 - nature.com
Genome-wide association studies (GWAS) and large-scale replication studies have identified
common variants in 79 loci associated with breast cancer, explaining ∼14% of the familial …
common variants in 79 loci associated with breast cancer, explaining ∼14% of the familial …
[HTML][HTML] Breast cancer quantitative proteome and proteogenomic landscape
In the preceding decades, molecular characterization has revolutionized breast cancer (BC)
research and therapeutic approaches. Presented herein, an unbiased analysis of breast …
research and therapeutic approaches. Presented herein, an unbiased analysis of breast …
Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170
…, MS Goldberg, SH Teo, CH Yip, S Nord… - Nature …, 2016 - nature.com
We analyzed 3,872 common genetic variants across the ESR1 locus (encoding estrogen
receptor α) in 118,816 subjects from three international consortia. We found evidence for at …
receptor α) in 118,816 subjects from three international consortia. We found evidence for at …
Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors
MicroRNAs (miRNAs) are endogenous non-coding RNAs, which play an essential role in the
regulation of gene expression during carcinogenesis. The role of miRNAs in breast cancer …
regulation of gene expression during carcinogenesis. The role of miRNAs in breast cancer …
[HTML][HTML] Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation
GWAS have identified a breast cancer susceptibility locus on 2q35. Here we report the fine
mapping of this locus using data from 101,943 subjects from 50 case-control studies. We …
mapping of this locus using data from 101,943 subjects from 50 case-control studies. We …
[HTML][HTML] Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
Common variants in 94 loci have been associated with breast cancer including 15 loci with
genome-wide significant associations (P<5 × 10 −8 ) with oestrogen receptor (ER)-negative …
genome-wide significant associations (P<5 × 10 −8 ) with oestrogen receptor (ER)-negative …
[HTML][HTML] Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
Background Breast cancer is a heterogeneous disease at the clinical and molecular level. In
this study we integrate classifications extracted from five different molecular levels in order …
this study we integrate classifications extracted from five different molecular levels in order …
[HTML][HTML] Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing
Background Single-cell micro-metastases of solid tumors often occur in the bone marrow.
These disseminated tumor cells (DTCs) may resist therapy and lay dormant or progress to …
These disseminated tumor cells (DTCs) may resist therapy and lay dormant or progress to …
[HTML][HTML] Glycan-related gene expression signatures in breast cancer subtypes; relation to survival
Alterations in glycan structures are early signs of malignancy and have recently been proposed
to be in part a driving force behind malignant transformation. Here, we explore whether …
to be in part a driving force behind malignant transformation. Here, we explore whether …